News Enzyvant gains double fast-track for rare disease drug Andrew McConaghie Breakthrough Therapy Designation, Enzyvant, Rare diseases, Regenerative Medicine Advanced Therapy, Vivek Ramaswamy 0 Comment Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare Share X Enzyvant gains double fast-track for rare disease drug https://pharmaphorum.com/news/enzyvant-gains-double-fast-track-rare-disease-drug/